Role of cell–matrix interactions on VIC phenotype and tissue deposition in 3D PEG hydrogels

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 10, 2016, Pages E443-E453

  Gould, Sarah T ^a   Anseth, Kristi S ^a,b  

^a UCB 450   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

3D; cell matrix interactions; ECM deposition; hydrogels; VICs; SMA

Indexed keywords

CELL ENGINEERING; CELLS; COLLAGEN; CYTOLOGY; DEPOSITION; ELASTIN; GELS; GLYCOPROTEINS; POLYETHYLENE GLYCOLS; SULFUR COMPOUNDS; TISSUE; TISSUE ENGINEERING;

3D; CELL FUNCTIONS; CELL MATRIX INTERACTIONS; CELL PHENOTYPE; ECM DEPOSITION; FUNCTIONALIZED; INTERSTITIALS; TISSUE DEPOSITION; VALVULAR INTERSTITIAL CELL; Α-SMOOTH MUSCLE ACTIN;

HYDROGELS;

ALPHA SMOOTH MUSCLE ACTIN; CHONDROITIN SULFATE; COLLAGEN TYPE 1; COLLAGEN TYPE 10; ELASTIN; FIBRONECTIN; MACROGOL; MATRIX METALLOPROTEINASE;

ANIMAL CELL; ANIMAL TISSUE; AORTA VALVE; AORTA VALVE STENOSIS; ARTICLE; CARDIAC MUSCLE CELL; CELL ACTIVATION; CELL ELONGATION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENCAPSULATION; ENZYME ACTIVITY; ENZYME RELEASE; EXTRACELLULAR MATRIX; HYDROGEL; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PIG; PRIORITY JOURNAL; VALVULAR INTERSTITIAL CELL;

EID: 85028270505     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1836     Document Type: Article

References (50)

1. Adelow C, Segura T, Hubbell JA, et al. 2008; The effect of enzymatically degradable poly(ethylene glycol) hydrogels on smooth muscle cell phenotype. Biomaterials 29: 314–326.
2. Benton JA, Fairbanks BD, Anseth KS. 2009; Characterization of valvular interstitial cell function in three dimensional matrix metalloproteinase degradable PEG hydrogels. Biomaterials 30: 6593–6603.
3. Bowman CN, Kloxin CJ. 2008; Toward an enhanced understanding and implementation of photopolymerization reactions. AIChE J 54: 2775–2795.
4. Chen JH, Simmons CA. 2011; Cell–matrix interactions in the pathobiology of calcific aortic valve disease. Circ Res 108: 1510–1524.
5. Chen JH, Chen WLK, Sider KL, et al. 2011; β-Catenin mediates mechanically regulated transforming growth factor-β1-induced myofibroblast differentiation of aortic valve interstitial cells. Arterioscler Thromb Vasc Biol 31: 590–597.
6. Chester AH, Taylor PM. 2007; Molecular and functional characteristics of heart-valve interstitial cells. Phil Trans R Soc B 362: 1437–1443.
7. Chester AH, Latif N, Yacoub MH, et al. 2008; Aortic valve: from function to tissue engineering. In Vascular Complications in Human Disease. Springer: London.
8. Clarke DR, Campbell DN, Hayward AR, et al. 1993; Degeneration of aortic valve allografts in young recipients. J Thorac Cardiovasc Surg 105: 934–941.
9. Cushing MC, Jaeggli MP, Masters KS, et al. 2005a; Serum deprivation improves seeding and repopulation of acellular matrices with valvular interstitial cells. J Biomed Mater Res A 75: 232–241.
10. Cushing MC, Liao JT, Anseth KS. 2005b; Activation of valvular interstitial cells is mediated by transforming growth factor-β1 interactions with matrix molecules. Matrix Biol 24: 428–437.
11. Durst CA, Cuchiara MP, Mansfield EG, et al. 2011; Flexural characterization of cell encapsulated PEGDA hydrogels with applications for tissue engineered heart valves. Acta Biomater 7: 2467–2476.
12. Engelmayr GC, Rabkin E, Sutherland FW, et al. 2005; The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue. Biomaterials 26: 175–187.
13. Fairbanks BD, Schwartz MP, Halevi AE, et al. 2009; A versatile synthetic extracellular matrix mimic via thiolene photopolymerization. Adv Mater 21: 5005–5010.
14. Filip DA, Radu A, Simionescu M. 1986; Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells. Circ Res 59: 310–320.
15. Flanagan TC, Wilkins B, Black A, et al. 2006; A collagen–glycosaminoglycan co-culture model for heart valve tissue engineering applications. Biomaterials 27: 2233–2246.
16. Gacchina CE, Deb PP, Barth J, et al. 2011; Elastogenic inductability of smooth muscle cells from a rat model of late-stage abdominal aortic aneurysms. Tissue Eng A 17: 1699–1711.
17. Gobin AS, West JL. 2003; Val–Ala–Pro–Gly, an elastin-derived non-integrin ligand: smooth muscle cell adhesion and specificity. J Biomed Mater Res A 67A: 255–259.
18. Gould ST, Darling NJ, Anseth KS. 2012; Small peptide functionalized thiolene hydrogels as culture substrates for understanding valvular interstitial cell activation and de novo tissue deposition. Acta Biomater 8: 3201–3209.
19. Gu X, Masters KS. 2010; Regulation of valvular interstitial cell calcification by adhesive peptide sequences. J Biomed Mater Res A 93A: 1620–1630.
20. Henaine R, Roubertie F, Vergnat M, et al. 2012; Valve replacement in children a challenge for a whole life. Arch Cardiovasc Dis 105: 517–528.
21. Hennessy K. 2009; The effect of collagen I mimetic peptides on mesenchymal stem cell adhesion and differentiation, and on bone formation at hydroxyapatite surfaces. Biomaterials 30: 1898–1909.
22. Hinek A. 1996; Biological roles of the non-integrin elastin/laminin receptor. Biol Chem 377: 471–480.
23. Hinz B. 2007; Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 127: 526–537.
24. Holledge MM, Millward-Sadler SJ, Nuki G. 2008; Mechanical regulation of proteoglycan synthesis in normal and osteoarthritic human articular chondrocytes – roles for α5 and αVβ5 integrins. Biorheology 45: 275–288.
25. Kloxin AM, Benton J, Anseth KS. 2009; In situ elasticity modulation with dynamic substrates to direct cell phenotype. Biomaterials 31: 1–8.
26. Le NT, Fleming BC. 2008; Measuring fixed charge density of goat articular cartilage using indentation methods and biochemical analysis. J Biomech 41: 715–720.
27. LeBaron RG, Athanasiou KA. 2000; Extracellular matrix cell adhesion peptides: functional applications in orthopedic materials. Tissue Eng 6: 85–103.
28. Lee DA, Assoku E, Doyle V. 1998; A specific quantitative assay for collagen synthesis by cells seeded in collagen-based biomaterials using Sirius red F3B precipitation. J Mater Sci Mater Med 9: 47–51.
29. Li C, Gotlieb AI. 2011; Transforming growth factor-β regulates the growth of valve interstitial cells in vitro. Am J Pathol 179: 1746–1755.
30. Lin CC, Raza A, Shih H. 2011; PEG hydrogels formed by thiolene photo-click chemistry and their effect on the formation and recovery of insulin-secreting cell spheroids. Biomaterials 32: 9685–9695.
31. Long JL, Tranquillo RT. 2003; Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol 22: 339–350.
32. MacNeil S, Bains S, Johson C. 2011; Gadolinium contrast agent associated stimulation of human fibroblast collagen production. Invest Radiol 46: 711–717.
33. Masters KS, Shah DN, Leinwand LA, et al. 2005; Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials 26: 2517–2525.
34. Ortega-Velazquez R, Diez-Marques ML, Ruiz-Torres MP, et al. 2003; Arg–Gly–Asp–Ser peptide stimulates transforming growth factor-β1 transcription and secretion through integrin activation. FASEB J 17: 1529–1531.
35. Patterson J, Hubbell JA. 2010; Enhanced proteolytic degradation of molecularly engineered PEG hydrogels in response to MMP-1 and MMP-2. Biomaterials 31: 7836–7845.
36. Pierschbacher MD, Ruoslahti E. 1984; Cell attachment activity of fFibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309: 30–33.
37. Ramaswamy S, Gottlieb D, Engelmayr GC, et al. 2010; The role of organ level conditioning on the promotion of engineered heart valve tissue development in vitro using mesenchymal stem cells. Biomaterials 31: 1114–1125.
38. Rodriguez MK, Rodriguez KJ, Masters KS. 2008; Regulation of valvular interstitial cell calcification by components of the extracellular matrix. J Biomed Mater Res A 90A: 1043–1053.
39. Rodriquez KJ, Piechura LM, Masters KS. 2011; Regulation of valvular interstitial cell phenotype and function by hyaluronic acid in 2D and 3D culture. Matrix Biol 30: 70–82.
40. Ruoslahti E. 1996; RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12: 697–715.
41. Sacks MS, Merryman WD, Schmidt DE. 2009; On the biomechanics of heart valve function. J Biomech 42: 1804–1824.
42. Schmidt O, Mizrahi J, Elisseeff J, et al. 2006; Immobilized fibrinogen in PEG hydrogels does not improve chondroctye-mediated matrix deposition in response to mechanical stimulation. Biotechnol Bioeng 95: 1061–1069.
43. Shah DN, Recktenwall-Work SM, Anseth KS. 2008; The effect of bioactive hydrogels on the secretion of extracellular matrix molecules by valvular interstitial cells. Biomaterials 29: 2060–2072.
44. Simionescu A, Philips K, Vyavahare N. 2005; Elastin-derived peptides and TGF-β1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun 334: 524–532.
45. Srokowski EM, Blit PH, McClung WG, et al. 2001; Platlet adhesion and fibrinogen accretion on a family of elastin-like polypeptides. J Biomater Sci Polymer Ed 22: 41–57.
46. Syedain ZH, Transquillo RT. 2009; Controlled cyclic stretch bioreactor for tissue-engineered heart valves. Biomaterials 30: 4078–4084.
47. Walker GA, Masters KS, Shah DN, et al. 2004; Valvular myofibroblast activation by transforming growth factor-β: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res 95: 253–260.
48. Wilda H, Merry CL, Blaker JJ. 2007; Three-dimensional culture of annulus fibrosus cells within PDLLA/Bioglass® composite foam scaffolds: assessment of cell attachment, proliferation and extracellular matrix production. Biomaterials 28: 2010–2020.
49. Wirrig EE, Hinton RB, Yutzey KE. 2011; Differential expression of cartilage and bone-related proteins in pediatric and adult diseased aortic valves. J Mol Cell Cardiol 50: 561–569.
50. Yip CY, Chen JH, Zhao R, et al. 2009; Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol 29: 936–942.